Highly expressed ILK was an independent poor prognostic factor for progression-free survival in patients with non-small-cell lung cancer (NSCLC) [79], while the knockdown of ILK gene made lung squamous cell carcinoma sensitive to TKI therapy [80]. The gene discussed is ILK; the disease is non-small cell lung carcinoma.